scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2567.2009.03076.X |
P698 | PubMed publication ID | 19740335 |
P50 | author | Daniele Noël | Q63405998 |
Christian Jorgensen | Q64004959 | ||
P2093 | author name string | Pierre Corbeau | |
Thierry Vincent | |||
Sylvie Fabre | |||
Caroline Desmetz | |||
Jacques Clot | |||
Pierre Portalès | |||
Brigitte Réant | |||
P2860 | cites work | TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression | Q22010551 |
Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura | Q33375482 | ||
Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression | Q33835337 | ||
Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis | Q34129985 | ||
Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis | Q35014330 | ||
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets | Q35111838 | ||
C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis | Q35126948 | ||
Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis | Q35554196 | ||
Rituximab: in rheumatoid arthritis | Q36951960 | ||
Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model | Q37383845 | ||
TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes | Q39077325 | ||
Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines | Q39112921 | ||
Acquisition of HIV type 1 resistance by beta-chemokine-producing CD4+ T cells | Q39202267 | ||
Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. | Q39269743 | ||
Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes | Q39343141 | ||
Endocytosis and recycling of the HIV coreceptor CCR5 | Q39461957 | ||
Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes | Q40158567 | ||
Genomic organization and transcriptional regulation of the RANTES chemokine gene | Q41532603 | ||
Chemokine production by human chondrocytes | Q42477798 | ||
Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo | Q45743773 | ||
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. | Q45743774 | ||
Regulation of CCR5 expression and MIP-1α production in CD4+ T cells from patients with rheumatoid arthritis | Q47969482 | ||
The delta32 deletion of CCR5 receptor in rheumatoid arthritis | Q47973433 | ||
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. | Q51978495 | ||
CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. | Q54020149 | ||
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis | Q57012210 | ||
Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice | Q57019206 | ||
CC chemokine receptor 5 polymorphism in rheumatoid arthritis | Q63728135 | ||
RANTES and chemokines in rheumatoid arthritis | Q71623497 | ||
Expression of the chemokine superfamily in rheumatoid arthritis | Q71645876 | ||
Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells | Q71708739 | ||
Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines | Q72072827 | ||
The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue | Q73006434 | ||
CXCR3 and CCR5 ligands in rheumatoid arthritis synovium | Q73352970 | ||
RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis | Q74002483 | ||
Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood | Q74561784 | ||
T cell activation in rheumatoid synovium is B cell dependent | Q74601890 | ||
RANTES expression and contribution to monocyte chemotaxis in arthritis | Q77359406 | ||
Selective lymphocyte chemokine receptor expression in the rheumatoid joint | Q77406819 | ||
Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis | Q77738063 | ||
Association of rheumatoid arthritis with a functional chemokine receptor, CCR5 | Q77738649 | ||
Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate | Q78178323 | ||
The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density | Q79440686 | ||
The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5 | Q80493657 | ||
P433 | issue | 1 Suppl | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | e738-45 | |
P577 | publication date | 2009-03-26 | |
P1433 | published in | Immunology | Q15754984 |
P1476 | title | Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody | |
P478 | volume | 128 |
Q35804294 | Chemokine receptors expression on peripheral CD4-lymphocytes in rheumatoid arthritis: Coexpression of CCR7 and CD95 is associated with disease activity. |
Q50872769 | Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis. |
Q90642824 | Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis |
Q38647749 | Successes and failures of chemokine-pathway targeting in rheumatoid arthritis |
Search more.